Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Showing 50 of 81 products
ImageCatalog NumberProduct NameSizePriceAdd to Cart
Breast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ERPM2a-ERBreast cancer with ER Immunohistochemistry control tissue array, including pathology grade, TNM, clinical stage and IHC results of ER/PR/Her-2/Ki67, 10 cases/10 cores, replacing PM2-ER
1 Each
Sign In for Pricing
Kidney cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/96 coresKD962Kidney cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/96 cores
1 Each
Sign In for Pricing
Penile cancer tissue array with normal penile skin as control tissue, including pathology grade, clinical TNM/stage (AJCC 8th edition), 80 cases/80 cores (core size 1.5mm), replacing PE801PE801aPenile cancer tissue array with normal penile skin as control tissue, including pathology grade, clinical TNM/stage (AJCC 8th edition), 80 cases/80 cores (core size 1.5mm), replacing PE801
1 Each
Sign In for Pricing
DLC-1, Control Peptide (Rho GTPase-activating Protein 7, Deleted in Liver Cancer 1 Protein, HP Protein, Rho-type GTPase-activating Protein 7, START Domain-containing Protein 12, StARD12, StAR-related Lipid Transfer Protein 12, DLC1, ARHGAP7, KIAA1723, STARD12)147849DLC-1, Control Peptide (Rho GTPase-activating Protein 7, Deleted in Liver Cancer 1 Protein, HP Protein, Rho-type GTPase-activating Protein 7, START Domain-containing Protein 12, StARD12, StAR-related Lipid Transfer Protein 12, DLC1, ARHGAP7, KIAA1723, STARD12)
100 µg
Sign In for Pricing
FAPP2, Control Peptide (Pleckstrin Homology Domain-containing Family A Member 8, PH Domain-containing Family A Member 8, Phosphatidylinositol-four-phosphate Adapter Protein 2, FAPP-2, Phosphoinositol 4-phosphate Adapter Protein 2, hFAPP2, Serologically Defined Breast Cancer Antigen NY-BR-86, PLEKHA8, MGC3358, DKFZp313M1034, DKFZp686J09164)147918FAPP2, Control Peptide (Pleckstrin Homology Domain-containing Family A Member 8, PH Domain-containing Family A Member 8, Phosphatidylinositol-four-phosphate Adapter Protein 2, FAPP-2, Phosphoinositol 4-phosphate Adapter Protein 2, hFAPP2, Serologically Defined Breast Cancer Antigen NY-BR-86, PLEKHA8, MGC3358, DKFZp313M1034, DKFZp686J09164)
100 µg
Sign In for Pricing
TPTE, Control Peptide (Transmembrane Phosphatase with Tensin Homology, Cancer/Testis Antigen 44, CT44, PTEN2, Putative Tyrosine Protein Phosphatase, Tumor Antigen BJ-HCC-5)148615TPTE, Control Peptide (Transmembrane Phosphatase with Tensin Homology, Cancer/Testis Antigen 44, CT44, PTEN2, Putative Tyrosine Protein Phosphatase, Tumor Antigen BJ-HCC-5)
100 µg
Sign In for Pricing
CEP290, Control Peptide (Centrosomal Protein of 290kD, Cep290, Bardet-Biedl Syndrome 14 Protein, Cancer/Testis Antigen 87, CT87, Nephrocystin-6, Tumor Antigen se2-2, BBS14, KIAA0373, NPHP6, FLJ13615, FLJ21979, JBTS5, JBTS6, 3H11Ag)148719CEP290, Control Peptide (Centrosomal Protein of 290kD, Cep290, Bardet-Biedl Syndrome 14 Protein, Cancer/Testis Antigen 87, CT87, Nephrocystin-6, Tumor Antigen se2-2, BBS14, KIAA0373, NPHP6, FLJ13615, FLJ21979, JBTS5, JBTS6, 3H11Ag)
100 µg
Sign In for Pricing
ANO1, Control Peptide (Anoctamin-1, Discovered on Gastrointestinal Stromal Tumors Protein 1, Oral Cancer Overexpressed Protein 2, Transmembrane Protein 16A, Tumor-amplified and Overexpressed Sequence 2, DOG1, ORAOV2, TAOS2, TMEM16A, FLJ10261)149304ANO1, Control Peptide (Anoctamin-1, Discovered on Gastrointestinal Stromal Tumors Protein 1, Oral Cancer Overexpressed Protein 2, Transmembrane Protein 16A, Tumor-amplified and Overexpressed Sequence 2, DOG1, ORAOV2, TAOS2, TMEM16A, FLJ10261)
50 µg
Sign In for Pricing
CRISP2, Control Peptide (Cysteine-rich Secretory Protein 2, CRISP-2, Cancer/Testis Antigen 36, CT36, Testis-specific Protein TPX-1, GAPDL5, TPX1)149479CRISP2, Control Peptide (Cysteine-rich Secretory Protein 2, CRISP-2, Cancer/Testis Antigen 36, CT36, Testis-specific Protein TPX-1, GAPDL5, TPX1)
50 µg
Sign In for Pricing
N33 (TUSC3, tumor suppressor candidate 3, D8S1992, MGC13453, N33, OST3A, Putative prostate cancer tumor suppressor) (Control Peptide) discontinuedN5379-06-PN33 (TUSC3, tumor suppressor candidate 3, D8S1992, MGC13453, N33, OST3A, Putative prostate cancer tumor suppressor) (Control Peptide) discontinued
100 µg
Sign In for Pricing
Colon cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC05012aBC05012bColon cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC05012a
1 Each
Sign In for Pricing
Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with TNM data-CR483CR483Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with TNM data-CR483
each
Sign In for Pricing
Colon cancer, colonic disease and normal colon control tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, TNM and clinical stage (AJCC 8th edition), 102 cases/102 cores (cores size 1.5mm), replacing CO1021aCO1021cColon cancer, colonic disease and normal colon control tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, TNM and clinical stage (AJCC 8th edition), 102 cases/102 cores (cores size 1.5mm), replacing CO1021a
1 Each
Sign In for Pricing
Lung squamous cell cancer tissue array with normal lung as control tissue, NSCLC, including TNM, clinical stage (AJCC 8th edition) and pathology grade,12 cases/24 cores (core size 1.5mm) .&nbspLC242cLung squamous cell cancer tissue array with normal lung as control tissue, NSCLC, including TNM, clinical stage (AJCC 8th edition) and pathology grade,12 cases/24 cores (core size 1.5mm) . 
1 Each
Sign In for Pricing
MUC13, Control Peptide (Mucin-13, MUC-13, Down-regulated in Colon Cancer 1, DRCC1, RECC, UNQ6194/PRO20221, FLJ20063)148198MUC13, Control Peptide (Mucin-13, MUC-13, Down-regulated in Colon Cancer 1, DRCC1, RECC, UNQ6194/PRO20221, FLJ20063)
100 µg
Sign In for Pricing
Lung squamous cell carcinoma tissue array with matched cancer adjacent tissue as controlLC1505Lung squamous cell carcinoma tissue array with matched cancer adjacent tissue as control
each
Sign In for Pricing
Testis cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases/24 coresT233Testis cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases/24 cores
1 Each
Sign In for Pricing
Colon cancer tissue array with matched adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 coresCO1504Colon cancer tissue array with matched adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores
1 Each
Sign In for Pricing
Head and neck cancer with normal control tissue array, including pathology grade and TNM, clinical stage (AJCC 8th edition), 131 cases/131 cores (core size 1.5mm), replacing HN1310HN1310aHead and neck cancer with normal control tissue array, including pathology grade and TNM, clinical stage (AJCC 8th edition), 131 cases/131 cores (core size 1.5mm), replacing HN1310
1 Each
Sign In for Pricing
BCAR3, Control Peptide (Breast Cancer Anti-estrogen Resistance Protein 3, Novel SH2-containing Protein 2, SH2 Domain-containing Protein 3B, NSP2, SH2D3B, UNQ271/PRO308)147705BCAR3, Control Peptide (Breast Cancer Anti-estrogen Resistance Protein 3, Novel SH2-containing Protein 2, SH2 Domain-containing Protein 3B, NSP2, SH2D3B, UNQ271/PRO308)
100 µg
Sign In for Pricing
NDC80, Control Peptide (Kinetochore Protein NDC80 Homolog, Highly Expressed in Cancer Protein, Kinetochore Protein Hec1, HsHec1, Kinetochore-associated Protein 2, Retinoblastoma-associated Protein HEC, HEC, HEC1, KNTC2)148045NDC80, Control Peptide (Kinetochore Protein NDC80 Homolog, Highly Expressed in Cancer Protein, Kinetochore Protein Hec1, HsHec1, Kinetochore-associated Protein 2, Retinoblastoma-associated Protein HEC, HEC, HEC1, KNTC2)
100 µg
Sign In for Pricing
Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 100 cases/ 100 cores, replacing BR1002aBR1002bBreast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 100 cases/ 100 cores, replacing BR1002a
1 Each
Sign In for Pricing
Ovary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases/70 cores, replacing OV702aOV702bOvary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases/70 cores, replacing OV702a
1 Each
Sign In for Pricing
Kidney cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 coresKD1503Kidney cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores
1 Each
Sign In for Pricing
Colon cancer tissue array with normal colon tissue as control, including pathology grade, TNM and clinical stage, 48 cases/48 cores, core size 2.0 mm.CO486aColon cancer tissue array with normal colon tissue as control, including pathology grade, TNM and clinical stage, 48 cases/48 cores, core size 2.0 mm.
1 Each
Sign In for Pricing
Breast cancer tissue array containing triple negative (TNBC) cases, including pathology grade, TNM, clinical stage and IHC results of ER, PR and Her-2 (6 cases of positive control), 120 cases/120 cores-BRE1201BRE1201Breast cancer tissue array containing triple negative (TNBC) cases, including pathology grade, TNM, clinical stage and IHC results of ER, PR and Her-2 (6 cases of positive control), 120 cases/120 cores-BRE1201
each
Sign In for Pricing
Liver cancer tissue array with normal liver tissue as control, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/ 24 cores, replacing T033aT033bLiver cancer tissue array with normal liver tissue as control, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/ 24 cores, replacing T033a
1 Each
Sign In for Pricing
Stomach cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/150 coresST1505Stomach cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/150 cores
1 Each
Sign In for Pricing
Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, cases/ cores, replacing LC807aLC807bLung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, cases/ cores, replacing LC807a
1 Each
Sign In for Pricing
Multiple liver cancer tissue array with 4 normal tissues control from autopsy, with TNM, 24 cases/48 coresLV482Multiple liver cancer tissue array with 4 normal tissues control from autopsy, with TNM, 24 cases/48 cores
1 Each
Sign In for Pricing
Zebra fish breast cancer 2, early onset (BRCA2) Control/blocking peptideAB-23033-PZebra fish breast cancer 2, early onset (BRCA2) Control/blocking peptide
100 µg
Sign In for Pricing
Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including duct adenocarcinoma ( PADC), cancer adjaceent pancreatic and normal tissue TNM, clinical stage and pathology grade, 80 cases/ 80 cores ( 1.5mm)-PA807PA807Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including duct adenocarcinoma ( PADC), cancer adjaceent pancreatic and normal tissue TNM, clinical stage and pathology grade, 80 cases/ 80 cores ( 1.5mm)-PA807
each
Sign In for Pricing
EBAG9, Control Peptide (Estrogen Receptor-binding Fragment-associated Gene 9 Protein, EB9, Cancer-associated Surface Antigen RCAS1, PDAF, Receptor-binding Cancer Antigen Expressed on SiSo Cells, RCAS1)147875EBAG9, Control Peptide (Estrogen Receptor-binding Fragment-associated Gene 9 Protein, EB9, Cancer-associated Surface Antigen RCAS1, PDAF, Receptor-binding Cancer Antigen Expressed on SiSo Cells, RCAS1)
100 µg
Sign In for Pricing
MIC1, Control Peptide (Uncharacterized Protein C18orf8, Colon Cancer-associated Protein Mic1, Mic-1, C18orf8, FLJ23453)148183MIC1, Control Peptide (Uncharacterized Protein C18orf8, Colon Cancer-associated Protein Mic1, Mic-1, C18orf8, FLJ23453)
100 µg
Sign In for Pricing
XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E) discontinued148687XAGE1, Control Peptide (G Antigen Family D Member 2, Cancer/Testis Antigen 12.1, CT12.1, Protein XAGE-1, XAGE1A, GAGED2, XAGE1B, XAGE1C, XAGE1D, XAGE1E) discontinued
100 µg
Sign In for Pricing
MLH1, Control Peptide, Human (MutL Homolog 1, MutL Protein Homolog 1, COCA2, DNA Mismatch Repair Protein Mlh1, FCC2, hMLH1, HNPCC, HNPCC2, MGC5172, MutL Homolog 1 Colon Cancer Nonpolyposis Type 2) discontinuedM3949-61HMLH1, Control Peptide, Human (MutL Homolog 1, MutL Protein Homolog 1, COCA2, DNA Mismatch Repair Protein Mlh1, FCC2, hMLH1, HNPCC, HNPCC2, MGC5172, MutL Homolog 1 Colon Cancer Nonpolyposis Type 2) discontinued
50 µg
Sign In for Pricing
Zebra fish breast cancer 2, early onset (BRCA2) Control/blocking peptideAB-23032-PZebra fish breast cancer 2, early onset (BRCA2) Control/blocking peptide
100 µg
Sign In for Pricing
PR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 coresPM2-PRPR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 cores
1 Each
Sign In for Pricing
Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores-SK484SK484Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores-SK484
each
Sign In for Pricing
Esophageal cancer tissue array with esophagus tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing ES482-ES482aES482aEsophageal cancer tissue array with esophagus tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing ES482-ES482a
each
Sign In for Pricing
Multiple organ cancer tissue array with matched non-metastatic lymph node tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores. The design and the corresponding MET961aNMET961Multiple organ cancer tissue array with matched non-metastatic lymph node tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores. The design and the corresponding MET961a
1 Each
Sign In for Pricing
Pancreatic cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 27 cases/ 81 coresPA811Pancreatic cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 27 cases/ 81 cores
1 Each
Sign In for Pricing
SRC3, Control Peptide, Human (Steroid receptor coactivator 3, NCOA3, Nuclear Receptor Coactivator 3, TRAM1, Thyroid Hormone Receptor Activator Molecule 1, RAC3, Receptor-Associated Coactivator 3, AIB1, Amplified in Breast Cancer-1, pCIP, CBP-Interacting protein) discontinuedS6505-08A1SRC3, Control Peptide, Human (Steroid receptor coactivator 3, NCOA3, Nuclear Receptor Coactivator 3, TRAM1, Thyroid Hormone Receptor Activator Molecule 1, RAC3, Receptor-Associated Coactivator 3, AIB1, Amplified in Breast Cancer-1, pCIP, CBP-Interacting protein) discontinued
50 µg
Sign In for Pricing
LDHC, Control Peptide (L-lactate Dehydrogenase C Chain, LDH-C, Cancer/Testis Antigen 32, CT32, LDH Testis Subunit, LDH-X, LDH3, LDHX, MGC111073)148131LDHC, Control Peptide (L-lactate Dehydrogenase C Chain, LDH-C, Cancer/Testis Antigen 32, CT32, LDH Testis Subunit, LDH-X, LDH3, LDHX, MGC111073)
100 µg
Sign In for Pricing
PDZD2, Control Peptide (PDZ Domain-containing Protein 2, Activated in Prostate Cancer Protein, PDZ Domain-containing Protein 3, AIPC, KIAA0300, PDZK3)148292PDZD2, Control Peptide (PDZ Domain-containing Protein 2, Activated in Prostate Cancer Protein, PDZ Domain-containing Protein 3, AIPC, KIAA0300, PDZK3)
100 µg
Sign In for Pricing
TSGA2, Control Peptide (Testis-specific Gene A2 Protein, TSA2, Radial Spoke Head 1 Homolog, RSPH1, Cancer/testis Antigen 79, CT79, Male Meiotic Metaphase Chromosome-associated Acidic Protein, Meichroacidin, RSP44, RSPH10A, FLJ32753, MGC126568, MGC141927)148986TSGA2, Control Peptide (Testis-specific Gene A2 Protein, TSA2, Radial Spoke Head 1 Homolog, RSPH1, Cancer/testis Antigen 79, CT79, Male Meiotic Metaphase Chromosome-associated Acidic Protein, Meichroacidin, RSP44, RSPH10A, FLJ32753, MGC126568, MGC141927)
100 µg
Sign In for Pricing
MACC1, Control Peptide (Metastasis-associated in Colon Cancer Protein 1, SH3 Domain-containing Protein 7a5)149231MACC1, Control Peptide (Metastasis-associated in Colon Cancer Protein 1, SH3 Domain-containing Protein 7a5)
50 µg
Sign In for Pricing
PTPRH, Control Peptide (Receptor-type Tyrosine-protein Phosphatase H, R-PTP-H, Stomach Cancer-associated Protein Tyrosine Phosphatase 1, SAP-1, Transmembrane-type Protein-tyrosine Phosphatase Type H, SAP1, FLJ39938, MGC133058, MGC133059)148781PTPRH, Control Peptide (Receptor-type Tyrosine-protein Phosphatase H, R-PTP-H, Stomach Cancer-associated Protein Tyrosine Phosphatase 1, SAP-1, Transmembrane-type Protein-tyrosine Phosphatase Type H, SAP1, FLJ39938, MGC133058, MGC133059)
100 µg
Sign In for Pricing
Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases/48 cores, with grade and stage dataCR482Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases/48 cores, with grade and stage data
1 Each
Sign In for Pricing
Stomach cancer tissue array with normal tissue as controlST1021Stomach cancer tissue array with normal tissue as control
each
Sign In for Pricing
1 2